Daniel Wintner Goodman - Net Worth and Insider Trading
Daniel Wintner Goodman Net Worth
The estimated net worth of Daniel Wintner Goodman is at least $0 dollars as of 2024-11-13. Daniel Wintner Goodman is the Director of Tonix Pharmaceuticals Holding Corp and owns about 1 shares of Tonix Pharmaceuticals Holding Corp (TNXP) stock worth over $0. Details can be seen in Daniel Wintner Goodman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel Wintner Goodman has not made any transactions after 2021-05-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel Wintner Goodman
Daniel Wintner Goodman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel Wintner Goodman owns 1 companies in total, including Tonix Pharmaceuticals Holding Corp (TNXP) .
Click here to see the complete history of Daniel Wintner Goodman’s form 4 insider trades.
Insider Ownership Summary of Daniel Wintner Goodman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TNXP | Tonix Pharmaceuticals Holding Corp | 2021-05-25 | director |
Daniel Wintner Goodman Latest Holdings Summary
Daniel Wintner Goodman currently owns a total of 1 stock. Daniel Wintner Goodman owns 1 shares of Tonix Pharmaceuticals Holding Corp (TNXP) as of May 25, 2021, with a value of $0.
Latest Holdings of Daniel Wintner Goodman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TNXP | Tonix Pharmaceuticals Holding Corp | 2021-05-25 | 1 | 0.15 | 0 |
Holding Weightings of Daniel Wintner Goodman
Daniel Wintner Goodman Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel Wintner Goodman has made a total of 1 transactions in Tonix Pharmaceuticals Holding Corp (TNXP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tonix Pharmaceuticals Holding Corp is the acquisition of 1 shares on May 25, 2021, which cost Daniel Wintner Goodman around $5,600.
Insider Trading History of Daniel Wintner Goodman
- 1
Daniel Wintner Goodman Trading Performance
GuruFocus tracks the stock performance after each of Daniel Wintner Goodman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel Wintner Goodman is -38.07%. GuruFocus also compares Daniel Wintner Goodman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel Wintner Goodman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel Wintner Goodman's insider trading performs compared to the benchmark.
Performance of Daniel Wintner Goodman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.25 | | | | | |
| Relative Return to S&P 500(%) | 4.04 | | | | | |
Daniel Wintner Goodman Ownership Network
Ownership Network List of Daniel Wintner Goodman
Ownership Network Relation of Daniel Wintner Goodman
Daniel Wintner Goodman Owned Company Details
What does Tonix Pharmaceuticals Holding Corp do?
Who are the key executives at Tonix Pharmaceuticals Holding Corp?
Daniel Wintner Goodman is the director of Tonix Pharmaceuticals Holding Corp. Other key executives at Tonix Pharmaceuticals Holding Corp include director & 10 percent owner & Chief Executive Officer Seth Lederman , Chief Medical Officer Gregory M Sullivan , and Chief Administrative Officer Jessica Edgar Morris .
Tonix Pharmaceuticals Holding Corp (TNXP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tonix Pharmaceuticals Holding Corp (TNXP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tonix Pharmaceuticals Holding Corp Insider Transactions
Daniel Wintner Goodman Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel Wintner Goodman. You might contact Daniel Wintner Goodman via mailing address: C/o Tonix Pharmaceuticals Holding Corp., 509 Madison Ave, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
